Concerted Cyclization of Lanosterol C-Ring and D-Ring Under Human Oxidosqualene Cyclase Catalysis: An ab Initio QM/MM MD Study.

Human oxidosqualene cyclase (OSC) is one key enzyme in the biosynthesis of cholesterol. It can catalyze the linear-chain 2,3-oxidosqualene to form lanosterol, the tetracyclic (6-6-6-5 members for A-B-C-D rings) cholesterol precursor. It also has been treated as a novel antihyperlipidemia target. In addition, the structural diversity of cyclic terpenes in plants originates from the cyclization of 2,3-oxidosqualene. The enzyme catalytic mechanism is considered to be one of the most complicated ones in nature, and there are a lot of controversies about the mechanism in the past half a century. Herein, state-of-the-art ab initio QM/MM MD simulations are employed to investigate the detailed cyclization mechanism of C-ring and D-ring formation. Our study reveals that the C and D rings are formed near-synchronously from a stable "6-6-5" ring intermediate. Interestingly, the transition state of this concerted reaction presents a "6-6-6" structure motif, while this unstable "6-6-6" structure in our simulations is thought to be a stable intermediate state in most previous hypothetical mechanisms. Furthermore, as the tailed side chain of 2,3-oxidosqualene shows a β conformation while it is α conformation in lanosterol, finally, it is observed that the rotatable "tail" chain prefers to transfer β conformation to α conformation at the "6-6-5" intermediate state.

[1]  David Beeman,et al.  Some Multistep Methods for Use in Molecular Dynamics Calculations , 1976 .

[2]  Ran Xu,et al.  On the origins of triterpenoid skeletal diversity. , 2004, Phytochemistry.

[3]  B. A. Hess,et al.  The concerted nature of the cyclization of squalene oxide to the protosterol cation. , 2013, Angewandte Chemie.

[4]  E. Corey,et al.  Conversion of a C20 2,3-oxidosqualene analog to tricyclic structures with a five-membered C-ring by lanosterol synthase. Further evidence for a C-ring expansion step in sterol biosynthesis , 1996 .

[5]  Hua Guo,et al.  Ab initio QM/MM free-energy studies of arginine deiminase catalysis: the protonation state of the Cys nucleophile. , 2011, The journal of physical chemistry. B.

[6]  H. Berendsen,et al.  Molecular dynamics with coupling to an external bath , 1984 .

[7]  P. Yeagle Modulation of membrane function by cholesterol. , 1991, Biochimie.

[8]  D. Tantillo Recent excursions to the borderlands between the realms of concerted and stepwise: carbocation cascades in natural products biosynthesis , 2008 .

[9]  Andrew Williams,et al.  Concerted Organic and Bio-organic Mechanisms , 1999 .

[10]  A. W. Burgstahler,et al.  The Stereochemistry of Polyene Cyclization , 1955 .

[11]  G. N. Sastry,et al.  Cation-π interaction: its role and relevance in chemistry, biology, and material science. , 2013, Chemical reviews.

[12]  J. Goldstein,et al.  Regulation of the mevalonate pathway , 1990, Nature.

[13]  R. Kahn,et al.  Chapter Six - Function and Evolution of Plant Cytochrome P450 , 2000 .

[14]  D. Truhlar,et al.  The M06 suite of density functionals for main group thermochemistry, thermochemical kinetics, noncovalent interactions, excited states, and transition elements: two new functionals and systematic testing of four M06-class functionals and 12 other functionals , 2008 .

[15]  Nathan A. Baker,et al.  PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations , 2004, Nucleic Acids Res..

[16]  Jiali Gao,et al.  Theoretical Evidence for a Concerted Mechanism of the Oxirane Cleavage and A-Ring Formation in Oxidosqualene Cyclization , 1998 .

[17]  M. Brown,et al.  Multivalent feedback regulation of HMG CoA reductase, a control mechanism coordinating isoprenoid synthesis and cell growth. , 1980, Journal of lipid research.

[18]  R. Swendsen,et al.  THE weighted histogram analysis method for free‐energy calculations on biomolecules. I. The method , 1992 .

[19]  G. Schulz,et al.  Enzyme Mechanisms for Polycyclic Triterpene Formation. , 2000, Angewandte Chemie.

[20]  W. L. Jorgensen,et al.  Comparison of simple potential functions for simulating liquid water , 1983 .

[21]  J. Deisenhofer,et al.  Structural Mechanism for Statin Inhibition of HMG-CoA Reductase , 2001, Science.

[22]  G. Prestwich,et al.  ENZYMATIC CYCLIZATION OF SQUALENE AND OXIDOSQUALENE TO STEROLS AND TRITERPENES , 1993 .

[23]  Kazuki Saito,et al.  Dual biosynthetic pathways to phytosterol via cycloartenol and lanosterol in Arabidopsis , 2009, Proceedings of the National Academy of Sciences.

[24]  Junmei Wang,et al.  Development and testing of a general amber force field , 2004, J. Comput. Chem..

[25]  M. Dewar Multibond reactions cannot normally be synchronous , 1984 .

[26]  Tai-Sung Lee,et al.  A pseudobond approach to combining quantum mechanical and molecular mechanical methods , 1999 .

[27]  J. Fruchart,et al.  Atherogenic Lipoprotein Particles in Atherosclerosis , 2004, Circulation.

[28]  Cheng-Hsiang Chang,et al.  Importance of Saccharomyces cerevisiae oxidosqualene-lanosterol cyclase tyrosine 707 residue for chair-boat bicyclic ring formation and deprotonation reactions. , 2008, Organic letters.

[29]  S. Eaton,et al.  Cholesterol in signal transduction. , 2000, Current opinion in cell biology.

[30]  Cheng-Hsiang Chang,et al.  Phenylalanine 445 within oxidosqualene-lanosterol cyclase from Saccharomyces cerevisiae influences C-Ring cyclization and deprotonation reactions. , 2006, Organic letters.

[31]  E. Corey,et al.  Methodology for the Preparation of Pure Recombinant S. cerevisiae Lanosterol Synthase Using a Baculovirus Expression System. Evidence That Oxirane Cleavage and A-Ring Formation Are Concerted in the Biosynthesis of Lanosterol from 2,3-Oxidosqualene , 1997 .

[32]  Shawn T. Brown,et al.  Advances in methods and algorithms in a modern quantum chemistry program package. , 2006, Physical chemistry chemical physics : PCCP.

[33]  O. Jeger,et al.  Zur Kenntnis der Triterpene. 190. Mitteilung. Eine stereochemische Interpretation der biogenetischen Isoprenregel bei den Triterpenen , 1955 .

[34]  T. Schulz-Gasch,et al.  Insight into steroid scaffold formation from the structure of human oxidosqualene cyclase , 2004, Nature.

[35]  John Z H Zhang,et al.  An efficient approach for ab initio energy calculation of biopolymers. , 2005, The Journal of chemical physics.

[36]  D. Tantillo,et al.  C–H⋯π interactions as modulators of carbocation structure – implications for terpene biosynthesis , 2013 .

[37]  T. Pedersen,et al.  Benefits and Risks of HMG-CoA Reductase Inhibitors in the Prevention of Coronary Heart Disease , 1996 .

[38]  T. Hoshino,et al.  Squalene-hopene cyclase: catalytic mechanism and substrate recognition. , 2002, Chemical communications.

[39]  Jiali Gao,et al.  Balancing kinetic and thermodynamic control: the mechanism of carbocation cyclization by squalene cyclase. , 2003, Journal of the American Chemical Society.

[40]  Yingkai Zhang,et al.  Pseudobond ab initio QM/MM approach and its applications to enzyme reactions , 2006 .

[41]  K. Bloch Biological synthesis of cholesterol. , 1965, Harvey lectures.

[42]  T. Hoshino,et al.  New cyclization mechanism for squalene: a ring-expansion step for the five-membered C-ring intermediate in hopene biosynthesis. , 1999, Bioscience, biotechnology, and biochemistry.

[43]  L. Juillerat-Jeanneret,et al.  Cytotoxic effects of combination of oxidosqualene cyclase inhibitors with atorvastatin in human cancer cells. , 2012, Journal of medicinal chemistry.

[44]  G. Prestwich,et al.  Photoaffinity labeling of oxidosqualene cyclase and squalene cyclase by a benzophenone-containing inhibitor. , 1998, Biochemistry.

[45]  A. Burlingame,et al.  Enzymic cyclization of trans,trans,trans-18,19-dihydrosqualene 2,3-oxide. , 1967, Journal of the American Chemical Society.

[46]  Cheng-Hsiang Chang,et al.  Saccharomyces cerevisiae oxidosqualene-lanosterol cyclase: a chemistry-biology interdisciplinary study of the protein's structure-function-reaction mechanism relationships. , 2008, Chemical record.

[47]  L. Smith,et al.  Another cholesterol hypothesis: cholesterol as antioxidant. , 1991, Free radical biology & medicine.

[48]  B. A. Hess,et al.  Concomitant C-ring Expansion and D-ring formation in lanosterol biosynthesis from squalene without violation of Markovnikov's rule. , 2002, Journal of the American Chemical Society.

[49]  R. Woodward,et al.  THE CYCLIZATION OF SQUALENE IN CHOLESTEROL SYNTHESIS , 1953 .

[50]  T. Hoshino,et al.  Further evidence that the polycyclization reaction by oxidosqualene-lanosterol cyclase proceeds via a ring expansion of the 5-membered C-ring formed by Markovnikov closure. On the enzymic products of the oxidosqualene analogue having an ethyl residue at the 15-position , 1998 .

[51]  P. Kollman,et al.  A well-behaved electrostatic potential-based method using charge restraints for deriving atomic char , 1993 .

[52]  K. B. Sharpless,et al.  Squalene-2,3oxide, an intermediate in the enzymatic conversion of squalene to lanosterol and cholesterol. , 1967, The Journal of biological chemistry.

[53]  G. Schulz,et al.  Binding structures and potencies of oxidosqualene cyclase inhibitors with the homologous squalene-hopene cyclase. , 2003, Journal of medicinal chemistry.

[54]  J. D. Willett,et al.  Enzymic conversion of squalene 2,3-oxide to lanosterol and cholesterol. , 1966, Journal of the American Chemical Society.

[55]  G. Torrie,et al.  Nonphysical sampling distributions in Monte Carlo free-energy estimation: Umbrella sampling , 1977 .

[56]  Benoît Roux,et al.  Extension to the weighted histogram analysis method: combining umbrella sampling with free energy calculations , 2001 .

[57]  B. A. Hess Formation of the C ring in the lanosterol biosynthesis from squalene. , 2003, Organic letters.

[58]  M. Schwartz,et al.  Nonenzymic laboratory cyclization of squalene 2,3-oxide. , 1966, Journal of the American Chemical Society.

[59]  T. Jarman,et al.  Investigations on the biosynthesis of steroids and terpenoids. Part XII. Biosynthesis of 3beta-hydroxy-triterpenoids and -steroids from (3S)-2,3-epoxy-2,3-dihydrosqualene. , 1975, Journal of the Chemical Society. Perkin transactions 1.

[60]  Weitao Yang,et al.  Free energy calculation on enzyme reactions with an efficient iterative procedure to determine minimum energy paths on a combined ab initio QM/MM potential energy surface , 2000 .

[61]  L. Eriksson,et al.  Catalytic mechanism and product specificity of oxidosqualene-lanosterol cyclase: a QM/MM study. , 2012, The journal of physical chemistry. B.

[62]  G. Ciccotti,et al.  Numerical Integration of the Cartesian Equations of Motion of a System with Constraints: Molecular Dynamics of n-Alkanes , 1977 .

[63]  E. Corey,et al.  Metabolic fate of 10,11-dihydrosqualene in sterol-producing rat liver homogenate. , 1966, Journal of the American Chemical Society.

[64]  Jiali Gao,et al.  Cation−π Interactions: An Energy Decomposition Analysis and Its Implication in δ-Opioid Receptor−Ligand Binding , 2002 .

[65]  D. Truhlar,et al.  Exploring the Limit of Accuracy of the Global Hybrid Meta Density Functional for Main-Group Thermochemistry, Kinetics, and Noncovalent Interactions. , 2008, Journal of chemical theory and computation.

[66]  Wei Zhang,et al.  A point‐charge force field for molecular mechanics simulations of proteins based on condensed‐phase quantum mechanical calculations , 2003, J. Comput. Chem..

[67]  M. Huff,et al.  Lord of the rings--the mechanism for oxidosqualene:lanosterol cyclase becomes crystal clear. , 2005, Trends in pharmacological sciences.

[68]  D. Tantillo Biosynthesis via carbocations: theoretical studies on terpene formation. , 2011, Natural product reports.

[69]  J. Slotte,et al.  Cholesterol interactions with phospholipids in membranes. , 2002, Progress in lipid research.

[70]  W. K. Wilson,et al.  Mechanistic insights into triterpene synthesis from quantum mechanical calculations. Detection of systematic errors in B3LYP cyclization energies. , 2006, Organic & biomolecular chemistry.

[71]  R. Paoletti,et al.  Safety of Statins: Focus on Clinical Pharmacokinetics and Drug Interactions , 2004, Circulation.

[72]  Nes Wd Biosynthesis of cholesterol and other sterols. , 2011 .

[73]  T. Haines,et al.  Do sterols reduce proton and sodium leaks through lipid bilayers? , 2001, Progress in lipid research.

[74]  G. Schulz,et al.  Structure and function of a squalene cyclase. , 1997, Science.

[75]  Søren Bak,et al.  On the origin of family 1 plant glycosyltransferases. , 2003, Phytochemistry.

[76]  S. Matsuda,et al.  Steric bulk at position 454 in Saccharomyces cerevisiae lanosterol synthase influences B-ring formation but not deprotonation. , 2000, Organic letters.

[77]  S. Oliaro-Bosso,et al.  Aminopropylindenes derived from Grundmann's ketone as a novel chemotype of oxidosqualene cyclase inhibitors. , 2013, European journal of medicinal chemistry.